Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism pendrin modulators(solute carrier family 26 member 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hearing Loss | Preclinical | AU | 01 Nov 2024 |